会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Recombinant antibody against human insulin-like growth factor
    • 针对人胰岛素样生长因子的重组抗体
    • US07498415B2
    • 2009-03-03
    • US10573378
    • 2004-09-24
    • Kenya ShitaraKazuyasu NakamuraYuji Ohki
    • Kenya ShitaraKazuyasu NakamuraYuji Ohki
    • C07K16/00C07K16/28
    • C07K16/2896C07K2317/73
    • It is demanded that pharmaceutical agents for therapeutic treatment of diseases such as cancer, acromegaly and diabetic complications, of which IGF is involved in the progress of the conditions.The present invention provides a recombinant antibody or an antibody fragment thereof which specifically binds to human insulin-like growth factor-I (hereinafter referred to as hIGF-I) and human insulin-like growth factor-II (hereinafter referred to as hIGF-II) to inhibit the biological activities of human IGF-I and human IGF-II, a transformant producing the antibody or the antibody fragment thereof, a process for producing the antibody or the antibody fragment thereof, and a medicament comprising the antibody or the antibody fragment thereof as the active ingredient therein.
    • 要求用于治疗治疗诸如癌症,肢端肥大症和糖尿病并发症的药剂,其中IGF涉及条件的进展。 本发明提供与人胰岛素样生长因子-1(以下称为hIGF-1)和人胰岛素样生长因子-II(以下称为hIGF-II)特异性结合的重组抗体或其抗体片段 )抑制人IGF-I和人IGF-II的生物活性,产生抗体或其抗体片段的转化体,制备抗体或其抗体片段的方法,以及包含抗体或抗体片段的药物 作为其中的活性成分。